Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026

Go back to Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026
(NASDAQ: RVMD) Delayed: 153.87 +4.64 (3.11%)
Previous Close $149.23    52 Week High
Open $150.40    52 Week Low
Day High $154.74    P/E N/A 
Day Low $149.67    EPS
Volume 1,581,059